Both
hyaluronic acid (HA) and
cyclooxygenase-2 (COX-2) inhibitors are used in clinical practice in the treatment of
osteoarthritis. There have been no reports regarding cross-talk between HA and
COX-2 inhibitors in articular human chondrocytes. The purpose of this study was to investigate whether HA,
COX-2 inhibitors or a combination of
COX-2 inhibitors and HA have different effects in human articular between lower and highly degenerated chondrocytes. Isolated lower and highly degenerated chondrocytes were divided into 5 groups:
ethanol (used as a control for the
solvents), HA,
COX-2 inhibitors,
COX-2 inhibitors plus HA, or no additive. After incubating for 48 h, mitochondrial membrane potential analysis and western blotting of p38 and p44/42
mitogen-activated protein kinase (MAPK) were performed.
Glycosaminoglycan,
nitric oxide (NO) production and
prostaglandin E2 (
PGE2) concentrations were assessed. A combination of
COX-2 inhibitors and HA resulted in dendritic, proliferating chondrocytes with strong red fluorescence enriched in the mitochondrial membrane, and indicated reduction of apoptosis in chondrocytes.
COX-2 inhibitors alone, and a combination of
COX-2 inhibitor and HA inhibited the activation of p38 in highly degenerated chondrocytes. A combination of
COX-2 inhibitors and HA decreased NO production in highly degenerated chondrocytes.
COX-2 inhibitors decreased
PGE2 production, however, HA alone had no effect on
PGE2 production. The present study demonstrated that
COX-2 inhibitors and HA interacted synergistically the MAPK pathway and inhibition of NO production in highly degenerated chondrocytes. Administration of
COX-2 inhibitors plus HA could be used as a new alternative way of treating
osteoarthritis.